)
Jubilant Life Sciences' manufacturing facility at Montreal, Canada, has got a clean chit from the US Food and Drug Administration (US FDA).
The facility, which had come under the American regulatory scanner after it received a warning letter last February, has resolved issues and has been been classified as 'acceptable' by the US FDA, Jubilant Life said in a statement.
"This resolves all issues raised by the FDA on the facility in February 2013 and subsequent communications", the statement said.
According to the statement, US FDA re-inspected Jubilant's Montreal facility in September 2013 and reviewed its responses before giving it a clean chit.
Jubilant Life Sciences manufactures and supplies active pharmaceutical ingredient (API), generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery and development. The company has 10 manufacturing facilities spread across India, the US and Canada.
